(Q46955354)

26 December 2017

title

Upregulation of immunomodulatory molecules by matrine treatment in experimental autoimmune encephalomyelitis (English)

1 reference

26 December 2017

author name string

Nan Liu

1

1 reference

26 December 2017

Quan-cheng Kan

2

1 reference

26 December 2017

Xiao-jian Zhang

3

1 reference

26 December 2017

Yu-ming Xv

4

1 reference

26 December 2017

Su Zhang

5

1 reference

26 December 2017

Guang-xian Zhang

6

1 reference

26 December 2017

Lin Zhu

7

1 reference

26 December 2017

publication date

7 October 2014

1 reference

26 December 2017

Experimental and Molecular Pathology

published in

1 reference

26 December 2017

volume

97

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

470-476

1 reference

26 December 2017

Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

T(H)-17 cells in the circle of immunity and autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Gender-specific expression of beta1 integrin of VLA-4 in myelin basic protein-primed T cells: implications for gender bias in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Current and emerging therapies in multiple sclerosis: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Th1 and Th2 lymphocytes in autoimmune disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Different therapeutic outcomes in experimental allergic encephalomyelitis dependent upon the mode of delivery of IL-10: a comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Tolerance induction in experimental autoimmune encephalomyelitis using non-myeloablative hematopoietic gene therapy with autoantigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Animal models of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Skewed immunological balance between Th17 (CD4(+)IL17A (+)) and Treg (CD4 (+)CD25 (+)FOXP3 (+)) cells in human oral squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Suppression by CD4+CD25+ regulatory T cells is dependent on expression of heme oxygenase-1 in antigen-presenting cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Distinct regulatory CD4+T cell subsets; differences between naïve and antigen specific T regulatory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Berberine activates Nrf2 nuclear translocation and protects against oxidative damage via a phosphatidylinositol 3-kinase/Akt-dependent mechanism in NSC34 motor neuron-like cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

In vivo-generated antigen-specific regulatory T cells treat autoimmunity without compromising antibacterial immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Matrine induces cell anergy in human Jurkat T cells through modulation of mitogen-activated protein kinases and nuclear factor of activated T-cells signaling with concomitant up-regulation of anergy-associated genes expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Treatment of experimental autoimmune encephalomyelitis in SJL/J mice with a replicative HSV-1 vector expressing interleukin-5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Redox regulation of cellular stress response in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Glatiramer acetate reduces lymphocyte proliferation and enhances IL-5 and IL-13 production through modulation of monocyte-derived dendritic cells in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Stage-specific immune dysregulation in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

TGF-β signaling initiated in dendritic cells instructs suppressive effects on Th17 differentiation at the site of neuroinflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Myeloid heme oxygenase-1 regulates innate immunity and autoimmunity by modulating IFN-beta production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Post-translational modification networks regulating FOXP3 function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Matrine, a novel autophagy inhibitor, blocks trafficking and the proteolytic activation of lysosomal proteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

The TGFbeta superfamily signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Adult neural stem cells expressing IL-10 confer potent immunomodulation and remyelination in experimental autoimmune encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Inhibitory effect of matrine on blood-brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Heme oxygenase-1 ameliorates dextran sulfate sodium-induced acute murine colitis by regulating Th17/Treg cell balance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

Matrine suppresses production of IL-23/IL-17 and ameliorates experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.10.004

10.1016/J.YEXMP.2014.10.004

7 January 2021

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

25303900

1 reference

26 December 2017